The role of the GPI anchor in Cripto signaling and forebrain specification

GPI 锚在 Cripto 信号传导和前脑规范中的作用

基本信息

  • 批准号:
    7667732
  • 负责人:
  • 金额:
    $ 2.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-01 至 2011-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Holoprosencephaly (HPE) is a developmental defect of the forebrain, which occurs in 1 out of 250 pregnancies. HPE is characterized by either forebrain truncation or failure of forebrain septation and various other midline defects. In the developing mouse embryo, the forebrain is first specified during gastrulation by the anterior visceral endoderm (AVE), an extra-embryonic tissue. The AVE specifies forebrain in the underlying embryonic tissue by blocking the signals from the primitive streak that provide posterior character to the tissue. As development proceeds, the AVE is displaced by the anterior definitive endoderm (ADE), which also has forebrain specification activity. Cripto, which is expressed in the posterior aspect of the gastrulating embryo, is critically involved in AVE migration and ADE specification. Cripto null embryos have severe gastrulation defects, whereas Cripto hypomorphs have HPE. I have isolated a mouse line, gonzo, that also displays gastrulation and HPE phenotypes. Furthermore, I have mapped the gene responsible for this mutation to a small region of chromosome 1, and have identified a mutation in Pig-N, a GPI-biosynthesis enzyme. Because the phenotypes of Cripto and gonzo mutants are strikingly similar, and because Cripto is a GPI-anchored protein, I will test the following hypotheses: First, HPE results from either an AVE migration defect or failure to specify the ADE. Second, the Pig-N mutation is responsible for the HPE phenotype. Third, aberrant GPI modification of Cripto disrupts Cripto signaling - and is the causative factor for the HPE phenotype. In this proposal I will complete the following aims: Aim 1: I will further characterize the HPE phenotype, and specifically look at specification of the AVE and ADE by examining molecular markers known to be involved in head morphogenesis. Aim 2: I will confirm that the mutation in Pig-N is responsible for the HPE phenotype and determine its effect on Pig-N stability, localization and activity. Aim 3: I will determine Cripto activity in gonzo embryos, and will attempt to rescue the phenotype by artificially targeting Cripto to its site of activation. Holoprosencephaly (which occurs in 1 out of 250 pregnancies) is characterized by forebrain defects; the most severe cases result in a single, cyclopic eye. I have identified a new gene in the mouse that results in holoprosencephaly when it is mutated. This proposal will identify the normal function of this gene thus leading to a better understanding of the causes of holoprosencephaly.
描述(由申请人提供):前脑畸形(HPE)是一种前脑发育缺陷,250例妊娠中有1例发生。HPE的特征是前脑截断或前脑分隔失败和各种其他中线缺陷。在发育中的小鼠胚胎中,前脑在原肠胚形成过程中首先由前内脏内胚层(AVE)指定,这是一种胚胎外组织。AVE通过阻断来自原始条纹的信号来指定胚胎组织中的前脑,而原始条纹为组织提供了后天性。随着发育的进行,AVE被前决定性内胚层(ADE)取代,后者也具有前脑规范活动。在原肠胚后部表达的Cripto在AVE迁移和ADE规范中起关键作用。隐胚无胚具有严重的原肠胚发育缺陷,而隐胚次胚具有HPE。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Mark McKean其他文献

David Mark McKean的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Mark McKean', 18)}}的其他基金

The role of the GPI anchor in Cripto signaling and forebrain specification
GPI 锚在 Cripto 信号传导和前脑规范中的作用
  • 批准号:
    7490658
  • 财政年份:
    2007
  • 资助金额:
    $ 2.65万
  • 项目类别:
The role of the GPI anchor in Cripto signaling and forebrain specification
GPI 锚在 Cripto 信号传导和前脑规范中的作用
  • 批准号:
    7900372
  • 财政年份:
    2007
  • 资助金额:
    $ 2.65万
  • 项目类别:
The role of the GPI anchor in Cripto signaling and forebrain specification
GPI 锚在 Cripto 信号传导和前脑规范中的作用
  • 批准号:
    7332943
  • 财政年份:
    2007
  • 资助金额:
    $ 2.65万
  • 项目类别:

相似海外基金

The role and clinical relevance of Activin receptor type 2A mutation in gastric cancer
激活素受体2A型突变在胃癌中的作用和临床相关性
  • 批准号:
    17K10579
  • 财政年份:
    2017
  • 资助金额:
    $ 2.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of Activin Receptor-like kinase 7 (ALK7) by cGMP in adipocytes
脂肪细胞中 cGMP 对激活素受体样激酶 7 (ALK7) 的调节
  • 批准号:
    242996745
  • 财政年份:
    2013
  • 资助金额:
    $ 2.65万
  • 项目类别:
    Research Grants
Activin receptor-based therapies for musculoskeletal disease
基于激活素受体的肌肉骨骼疾病疗法
  • 批准号:
    8900181
  • 财政年份:
    2011
  • 资助金额:
    $ 2.65万
  • 项目类别:
Activin receptor-based therapies for musculoskeletal disease
基于激活素受体的肌肉骨骼疾病疗法
  • 批准号:
    8700904
  • 财政年份:
    2011
  • 资助金额:
    $ 2.65万
  • 项目类别:
Activin receptor-based therapies for musculoskeletal disease
基于激活素受体的肌肉骨骼疾病疗法
  • 批准号:
    8220374
  • 财政年份:
    2011
  • 资助金额:
    $ 2.65万
  • 项目类别:
Activin receptor-based therapies for musculoskeletal disease
基于激活素受体的肌肉骨骼疾病疗法
  • 批准号:
    8512558
  • 财政年份:
    2011
  • 资助金额:
    $ 2.65万
  • 项目类别:
Activin receptor-based therapies for musculoskeletal disease
基于激活素受体的肌肉骨骼疾病疗法
  • 批准号:
    8706800
  • 财政年份:
    2011
  • 资助金额:
    $ 2.65万
  • 项目类别:
Activin receptor-based therapies for musculoskeletal disease
基于激活素受体的肌肉骨骼疾病疗法
  • 批准号:
    8335476
  • 财政年份:
    2011
  • 资助金额:
    $ 2.65万
  • 项目类别:
Genes regulated by activin receptor II signaling in gonadotropes
促性腺激素中受激活素受体 II 信号传导调节的基因
  • 批准号:
    7614334
  • 财政年份:
    2008
  • 资助金额:
    $ 2.65万
  • 项目类别:
Activin Receptor-Like Kinase-2 in Cardiac Morphogenesis
心脏形态发生中的激活素受体样激酶 2
  • 批准号:
    6844624
  • 财政年份:
    2004
  • 资助金额:
    $ 2.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了